In contrast, a small study on HNSCC patients showed a reduction in plasma uPAR (n = 11), but the patients were referred to surgery and the timing of the samples were varying (1–42 days post-treatment)13. The gene discussed is PLAUR; the disease is head and neck squamous cell carcinoma.